The ser-thr Akt plays a critical role in the regulation of cell survival, cell growth and proliferation, as well as energy metabolism and is dysregulated in many cancers. The regulation of Akt activity depends on the phosphorylation at two sites: (i) Thr308 in the activation loop by phosphoinositide-dependent kinase-1 (PDK1) and (ii) Ser473 hydrophobic motif at the carboxyl terminus by a second activity termed PDK2, which is the mTORC2 complex composed of mTOR, rictor, and Sin1. Previously we demonstrated that IKKα, a component of the IKK complex that controls NF-κB activation, participates in the Akt-dependent regulation of mTORC1. Here we have explored a potential involvement of IKKα in controlling Akt activity and whether this may involv...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
Growth factor signaling promotes anabolic processes via activation of the PI3K-Akt kinase cascade. D...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
The ser-thr Akt plays a critical role in the regulation of cell survival, cell growth and proliferat...
The serine/threonine protein kinase Akt promotes cell survival, growth, and proliferation through ph...
The serine/threonine protein kinase Akt promotes cell survival, growth, and proliferation through ph...
While NF-κB is considered to play key roles in the development and progression of many cancers, the ...
While NF-κB is considered to play key roles in the development and progression of many cancers, the ...
SummaryThe downstream effector of PI3K, Akt, is frequently hyperactivated in human cancers. A critic...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. Prolonged treatme...
Growth factor signaling promotes anabolic processes via activation of the PI3K-Akt kinase cascade. D...
Mutations leading to inappropriate activation of Akt isoforms contribute to proliferation and surviv...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
Mutations leading to inappropriate activation of Akt isoforms contribute to proliferation and surviv...
Mutations leading to inappropriate activation of Akt isoforms contribute to proliferation and surviv...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
Growth factor signaling promotes anabolic processes via activation of the PI3K-Akt kinase cascade. D...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
The ser-thr Akt plays a critical role in the regulation of cell survival, cell growth and proliferat...
The serine/threonine protein kinase Akt promotes cell survival, growth, and proliferation through ph...
The serine/threonine protein kinase Akt promotes cell survival, growth, and proliferation through ph...
While NF-κB is considered to play key roles in the development and progression of many cancers, the ...
While NF-κB is considered to play key roles in the development and progression of many cancers, the ...
SummaryThe downstream effector of PI3K, Akt, is frequently hyperactivated in human cancers. A critic...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. Prolonged treatme...
Growth factor signaling promotes anabolic processes via activation of the PI3K-Akt kinase cascade. D...
Mutations leading to inappropriate activation of Akt isoforms contribute to proliferation and surviv...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
Mutations leading to inappropriate activation of Akt isoforms contribute to proliferation and surviv...
Mutations leading to inappropriate activation of Akt isoforms contribute to proliferation and surviv...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
Growth factor signaling promotes anabolic processes via activation of the PI3K-Akt kinase cascade. D...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...